tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP

Adaptimmune Therapeutics (ADAP) Stock Investors

724 Followers
Based on 746,321 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ADAP
On average, investors allocate 2.53% of their portfolios to ADAP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,321 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ADAP

1.7%
Last 7
Days
4.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ADAP, out of 746,321 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ADAP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
<0.01%
$1.54
Based on the activity of 14,167 investors who made their portfolios public
The table shows changes in ADAP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ADAP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.17%
-0.64%
+1.88%
81.39B
Healthcare
DraftKings
5.80%
-1.24%
-1.57%
34.65B
Consumer Cyclical
Coherus Biosciences
2.54%
-1.55%
-5.22%
189.30M
Healthcare
Block
4.20%
-0.51%
+0.84%
44.46B
Technology
Merck & Company
3.90%
+0.82%
+4.38%
324.50B
Healthcare
GE Aerospace
5.17%
-0.65%
+1.07%
174.66B
Industrials
Baidu
5.26%
+2.60%
+14.57%
34.93B
Communication Services
Trade Desk
4.65%
-0.68%
+2.55%
48.96B
Technology
Applied Materials
4.70%
+0.31%
+6.56%
203.31B
Technology
Riot Platforms
4.90%
-0.84%
+0.64%
3.32B
Financial
Based on the activity of 746,321 active portfolios
Open your Smart Portfolio

ADAP Investor Analysis

ADAP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.2%
of ADAP holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
ADAP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.6%
of ADAP holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
ADAP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
28.3%
of ADAP holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of ADAP stock investors
See who invests in ADAP according to age group and performance.

FAQ

How many retail Investors hold ADAP?
<0.1% of TipRanks' retail investors hold ADAP in their portfolios.
    What is ADAP Investor Sentiment?
    ADAP’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of ADAP in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of ADAP in the last 7 days.
        What percentage of retail investors changed their holding of ADAP in the last 30 days?
        ▲ 4.1% of TipRanks' retail investors changed their holding of ADAP in the last 30 days.
          What is the average age of retail investors who hold ADAP?
          The average age of ADAP Holders is between 35–55.
            What other stocks have ADAP investors also bought?
            ADAP Investors also bought BMY, DKNG, CHRS, SQ, MRK, GE, BIDU, TTD, AMAT, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              BCRXBioCryst
              BSXBoston Scientific
              CYTKCytokinetics
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis